| Literature DB >> 25773499 |
J E Locke1, R D Reed1, S G Mehta2, C Durand3, R B Mannon2, P MacLennan1, B Shelton1, M Y Martin4, H Qu5, R Shewchuk5, D L Segev3,6.
Abstract
Excellent outcomes among HIV+ kidney transplant (KT) recipients have been reported by the NIH consortium, but it is unclear if experience with HIV+ KT is required to achieve these outcomes. We studied associations between experience measures and outcomes in 499 HIV+ recipients (SRTR data 2004-2011). Experience measures examined included: (1) center-level participation in the NIH consortium; (2) KT experiential learning curve; and (3) transplant era (2004-2007 vs. 2008-2011). There was no difference in outcomes among centers early in their experience (first 5 HIV+ KT) compared to centers having performed >6 HIV+ KT (GS adjusted hazard ratio [aHR]: 1.05, 95% CI: 0.68-1.61, p = 0.82; PS aHR: 0.93; 95% CI: 0.56-1.53, p = 0.76), and participation in the NIH-study was not associated with any better outcomes (GS aHR: 1.08, 95% CI: 0.71-1.65, p = 0.71; PS aHR: 1.13; 95% CI: 0.68-1.89, p = 0.63). Transplant era was strongly associated with outcomes; HIV+ KTs performed in 2008-2011 had 38% lower risk of graft loss (aHR: 0.62; 95% CI: 0.42-0.92, p = 0.02) and 41% lower risk of death (aHR: 0.59; 95% CI: 0.39-0.90, p = 0.01) than that in 2004-2007. Outcomes after HIV+ KT have improved over time, but center-level experience or consortium participation is not necessary to achieve excellent outcomes, supporting continued expansion of HIV+ KT in the US. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: (SRTR); Scientific Registry for Transplant Recipients; clinical research/practice; graft survival; health services and outcomes research; infection and infectious agents; infectious disease; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; patient survival; viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
Mesh:
Year: 2015 PMID: 25773499 PMCID: PMC5933060 DOI: 10.1111/ajt.13220
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086